ProSomnus (OSA) Revenue & Revenue Breakdown
ProSomnus Revenue Highlights
Latest Revenue (Y)
$27.65M
Latest Revenue (Q)
$7.46M
ProSomnus Revenue by Period
ProSomnus Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $27.65M | 42.59% |
| 2022-12-31 | $19.39M | 37.79% |
| 2021-12-31 | $14.07M | 69.86% |
| 2020-12-31 | $8.29M | - |
ProSomnus generated $27.65M in revenue during NA 2023, up 42.59% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
ProSomnus Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $7.46M | -4.85% |
| 2023-12-31 | $7.84M | 10.84% |
| 2023-09-30 | $7.07M | 1.98% |
| 2023-06-30 | $6.93M | 19.38% |
| 2023-03-31 | $5.81M | 0.28% |
| 2022-12-31 | $5.79M | 15.89% |
| 2022-09-30 | $5.00M | 2.84% |
| 2022-06-30 | $4.86M | 29.83% |
| 2022-03-31 | $3.74M | -14.99% |
| 2021-12-31 | $4.40M | 18.92% |
| 2021-09-30 | $3.70M | 7.70% |
| 2021-06-30 | $3.44M | 15.18% |
| 2021-03-31 | $2.98M | - |
ProSomnus generated $7.46M in revenue during Q1 2024, up -4.85% compared to the previous quarter, and up 128.76% compared to the same period a year ago.
ProSomnus Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $746.27M |
| CNMD | CONMED | $1.24B | $316.70M |
| LIVN | LivaNova | $1.15B | $318.11M |
| AORT | Artivion | $354.00M | $95.78M |
| ANIK | Anika Therapeutics | $166.66M | $38.75M |
| ESTA | Establishment Labs | $165.15M | $40.23M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| IRMD | IRadimed | $65.56M | $18.33M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| CVRX | CVRx | $39.30M | $13.37M |
| OSA | ProSomnus | $27.65M | $7.46M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |